Sale!

MECP2 Full Gene Mutation Analysis Rett Syndrome Test Cost

Original price was: 4,000 د.إ.Current price is: 3,000 د.إ.

-25%

The MECP2 Full Gene Mutation Analysis Rett Syndrome Test is a specialized genetic test designed to identify mutations in the MECP2 gene, which are strongly associated with Rett Syndrome, a rare neurodevelopmental disorder primarily affecting females. This comprehensive analysis helps in the early detection and diagnosis of Rett Syndrome, enabling timely intervention and management of the condition. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the entire MECP2 gene for any mutations. The cost of the test is 3000 AED, reflecting the advanced technology and expertise required to conduct this intricate analysis. By identifying specific genetic mutations, the test provides crucial information for families and healthcare providers, facilitating personalized care plans and improving the quality of life for those affected by Rett Syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MECP2 Full Gene Mutation Analysis RETT Syndrome Test

At DNA Labs UAE, we offer the MECP2 Full Gene Mutation Analysis RETT Syndrome Test for the diagnosis of Rett syndrome. Rett syndrome is a neurodevelopmental disorder that primarily affects girls. It is caused by mutations in the MECP2 gene, which is located on the X chromosome.

Test Details

The MECP2 Full Gene Mutation Analysis involves sequencing the entire MECP2 gene to identify any mutations or changes in the gene sequence. This test is typically performed on a blood sample or a sample of saliva. The test components include an EDTA Vacutainer (2ml).

Test Cost and Report Delivery

The cost of the MECP2 Full Gene Mutation Analysis RETT Syndrome Test is 3000.0 AED. The report will be delivered within 8-10 days.

Method and Test Type

The MECP2 Full Gene Mutation Analysis is performed using Sanger Sequencing, a method commonly used in genetics testing. This test falls under the genetics test category.

Referring Doctor and Test Department

The referring doctor for this test is a Gynecologist. The test is conducted in our Genetics Test Department.

Pre Test Information

A Doctors prescription is required for the MECP2 Full Gene Mutation Analysis RETT Syndrome Test. However, it is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Symptoms and Diagnosis

Rett syndrome is characterized by various symptoms, including a loss of purposeful hand skills, a regression of acquired skills, loss of verbal communication, stereotypic hand movements (such as hand-wringing or hand-washing), and the development of breathing abnormalities. These symptoms usually become apparent between 6 and 18 months of age.

By identifying mutations in the MECP2 gene, the MECP2 Full Gene Mutation Analysis can provide a definitive diagnosis of Rett syndrome. This information is crucial for understanding the cause of the disorder and for providing appropriate medical management and support for affected individuals and their families.

Test Name MECP2 Full Gene Mutation Analysis RETT Syndrome Test
Components EDTA Vacutainer (2ml)
Price 3000.0 AED
Sample Condition Peripheral blood
Report Delivery 8-10 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information MECP2 Full Gene Mutation Analysis (RETT Syndrome) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

MECP2 Full Gene Mutation Analysis is a genetic test used to diagnose Rett syndrome, a neurodevelopmental disorder that primarily affects girls. Rett syndrome is caused by mutations in the MECP2 gene, which is located on the X chromosome.

The MECP2 Full Gene Mutation Analysis involves sequencing the entire MECP2 gene to identify any mutations or changes in the gene sequence. This test is typically performed on a blood sample or a sample of saliva.

Rett syndrome is characterized by a loss of purposeful hand skills, a regression of acquired skills, loss of verbal communication, stereotypic hand movements (such as hand-wringing or hand-washing), and the development of breathing abnormalities. These symptoms usually become apparent between 6 and 18 months of age.

By identifying mutations in the MECP2 gene, the MECP2 Full Gene Mutation Analysis can provide a definitive diagnosis of Rett syndrome. This information is important for understanding the cause of the disorder and for providing appropriate medical management and support for affected individuals and their families.